ASTM E1208-99

1.1 This test method covers procedures for fluorescent liquid penetrant examination utilizing the lipophilic post- emulsification process. It is a nondestructive testing method for detecting discontinuities that are open to the surface such as cracks, seams, laps, cold shuts, laminations, through leaks, or lack of fusion and is applicable to in-process, final, and maintenance examination. It can be effectively used in the examination of nonporous, metallic materials, both ferrous and of nonmetallic materials such as glazed or fully densified ceramics and certain nonporous plastics and glass.

1.2 This test method also provides a reference:

1.2.1 By which a fluorescent liquid penetrant examination, lipophilic post-emulsification process recommended or required by individual organizations can be reviewed to ascertain its applicability and completeness.

1.2.2 For use in the preparation of process specifications dealing with the fluorescent penetrant examination of materials and parts using the lipophilic post-emulsification process. Agreement by the purchaser and the manufacturer regarding specific techniques is strongly recommended.

1.2.3 For use in the organization of the facilities and personnel concerned with the liquid penetrant examination.

1.3 This test method does not indicate or suggest standards for evaluation of the indications obtained. It should be noted, however, that after indications have been produced, they must be interpreted or classified and then evaluated. For this purpose there must be a separate code or specification or a specific agreement to define the type, size, location, and direction of indications considered acceptable, and those considered unacceptable.

1.4 The values stated in inch-pound units are to be regarded as the standard. SI units are provided for information only.

1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. For specific hazard statements, see Notes 5, 13, and 19.